Alex F Herrera (Alex Herrera)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 62

Top Topics

Hodgkin Lymphoma

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Phillip Gordon Braun, Alex F Herrera
Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse. Leukemia & lymphoma (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38 (7) (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia (2024)
Cathy Burton, Pamela Allen, Alex F Herrera
Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38 (7) (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38 (7) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
Tamer Othman, John H Baird, Stacy Pak, Matthew G Mei, Alex F Herrera, Joshua Mansour, Geoffrey Shouse, Firoozeh Sahebi, Ricardo Spielberger, Ji-Lian Cai, Leonardo Farol, James Godfrey, Avyakta Kallam, Tycel Phillips, Leslie Popplewell, Tanya Siddiqi, Stephen Forman, L Elizabeth Elizabeth Budde
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma. British journal of haematology (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38 (7) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Cathy Burton, Pamela Allen, Alex F Herrera
Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood 144 (4) (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38 (7) (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Mueller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory Hodgkin Lymphoma: a Propensity Score Matched Analysis. Blood advances (2024)
Jasmine M Zain, Ni-Chun Tsai, Joycelynne M Palmer, Jennifer R Simpson, Vikram Adhikarla, James Bading, Paul Yazaki, Eileen Patricia Smith, Savita Dandapani, Joo Y Song, Nicole A Karras, Alex F Herrera, Amandeep Salhotra, Auayporn Nademanee, Ryotaro Nakamura, D Lynne Smith, Dave M Yamauchi, Erasmus Kofi Poku, Van Eric Biglang-Awa, Sandra Holley Thomas, David Colcher, John E Shively, Anna M Wu, Stephen J Forman, Jeffrey Yc Wong
Yttrium-90 Anti-CD25-BEAM-Conditioning for Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphoma. Blood advances (2024)
Ariela L Marshall, Leah E Masselink, Peter A Kouides, Faith E Davies, Azam Farooqui, Srikanth Nagalla, Alex F Herrera, Nicole Mortier, Robert A Brodsky, Clese E Erikson
Advanced practice providers in hematology: actionable findings from national paired APP and physician surveys. Blood advances 8 (5) (2024)
Trent P Wang, Kwang W Ahn, Mazyar Shadman, Manmeet Kaur, Nausheen Ahmed, Ulrike Bacher, Jan Cerny, Andy Chen, Narendranath Epperla, Matthew Frigault, Natalie Grover, Bradley M Haverkos, Brian Hill, Nasheed M Hossain, Madiha Iqbal, Tania Jain, Maxwell M Krem, Joseph E Maakaron, Dipenkumar Modi, Muhamad Alhaj Moustafa, Peter Riedell, Bipin P Savani, R Alejandro Sica, Anna Sureda, Kitsada Wudhikarn, Alex F Herrera, Craig Sauter, Mehdi Hamadani, Antonio Jimenez Jimenez
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38 (7) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Ariela L Marshall, Leah E Masselink, Peter A Kouides, Faith E Davies, Azam Farooqui, Srikanth Nagalla, Alex F Herrera, Nicole Mortier, Robert A Brodsky, Clese E Erikson
Advanced practice providers in hematology: actionable findings from national paired APP and physician surveys. Blood advances 8 (5) (2024)
Narendranath Epperla, Ying Huang, Amanda F Cashen, John L Vaughn, Walter Hanel, Talha Badar, Stefan K Barta, Paolo F Caimi, Tarsheen K Sethi, Nishitha Reddy, Reem Karmali, Celeste Bello, Julio C Chavez, Shalin K Kothari, Francisco J Hernandez-Ilizaliturri, Jakub Svoboda, Frederick Lansigan, Martha J Glenn, Jonathon B Cohen, Caryn Sorge, Beth Christian, Alex F Herrera, Mehdi Hamadani, Luciano José Megale Costa, Ana C Xavier
Evaluation of prognostic factors for high-risk classical Hodgkin lymphoma undergoing autologous transplantation. Blood advances (2024)
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Luigi Zinzani, Ann Steward LaCasce, Peter D Cole, Craig H Moskowitz, Miriam Santero, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée J M Zijlstra-Baalbergen, Barbara A Hutten, Alison J Moskowitz, Marie José Kersten
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis. Blood advances 8 (11) (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria R Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin M Parsons, Paolo Caimi, Ian W Flinn, Alex F Herrera, Jeff P Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy. Blood (2024)
Tamer Othman, John H Baird, Stacy Pak, Matthew G Mei, Alex F Herrera, Joshua Mansour, Geoffrey Shouse, Firoozeh Sahebi, Ricardo Spielberger, Ji-Lian Cai, Leonardo Farol, James Godfrey, Avyakta Kallam, Tycel Phillips, Leslie Popplewell, Tanya Siddiqi, Stephen Forman, L Elizabeth Elizabeth Budde
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma. British journal of haematology 205 (1) (2024)
Priyanka A Pophali, Joshua A Fein, Kwang Woo Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T Awan, Shatha Farhan, Natalie Sophia Grover, Talal Hilal, Madiha Iqbal, Joeseph Maakaron, Dipenkumar Modi, Elham Nasrollahi, Levanto Schachter, Craig S Sauter, Mehdi Hamadani, Alex F Herrera, Roni Shouval, Mazyar Shadman
CD19-directed CART Therapy for T cell/Histiocyte Rich Large B-cell Lymphoma. Blood advances (2024)
James K Godfrey, Lei Gao, Geoffrey Shouse, Joo Y Song, Stacy Pak, Brian Lee, Bihong T Chen, Avyakta Kallam, John H Baird, Guido Marcucci, Lucy Y Ghoda, Stephanie Vauleon, Alexey V Danilov, Alex F Herrera, Larry W Kwak, L Elizabeth Elizabeth Budde
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma. Blood (2024)
Matthew G Mei, Alex F Herrera
The next frontier: enter PD-1 and exit PET scans? Blood 141 (21) (2023)
Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, David Bernard Miklos, Lazaros J Lekakis, Olalekan O Oluwole, Yi Lin, Ira Braunschweig, Brian T Hill, John M Timmerman, Abhinav Deol, Patrick M Reagan, Patrick Joseph Stiff, Ian W Flinn, Umar Farooq, Andre H Goy, Peter McSweeney, Javier L Muñoz, Tanya Siddiqi, Julio C Chavez, Alex F Herrera, Nancy L Bartlett, Adrian A Bot, Rhine R Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J Kim, Yan Zheng, Frederick L Locke
5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1). Blood (2023)
Matthew G Mei, Lu Chen, James K Godfrey, Joo Y Song, Colt A Egelston, L Elizabeth Elizabeth Budde, Saro H Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, Peter Lee, Robert W Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Jasmine Zain, Steven T Rosen, Stephen J Forman, Leslie L Popplewell, Larry W Kwak, Alex F Herrera
Pembrolizumab plus vorinostat is highly active in Hodgkin lymphoma, including patients refractory to prior PD-1 blockade. Blood (2023)
Tycel Jovelle Phillips, David A Bond, Radhika Takiar, Karson J Kump, Malathi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria R Nachar, Ryan A Wilcox, Shannon Ann Carty, Yasmin H Karimi, Zaneta Nikolovska-Coleska, Mark S Kaminski, Alex F Herrera, Kami Maddocks, Leslie L Popplewell, Alexey V Danilov
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma. Blood advances (2023)
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F Herrera, David C Fisher, Ann Steward LaCasce, Oreofe O Odejide, Samuel Y Ng, Caron A Jacobson, Reid W Merryman, Austin I Kim, Yago L Nieto, Craig S Sauter, Gunjan L Shah, Jasmine Zain, Philippe Armand, Eric D Jacobsen
A Phase 2 Study of pembrolizumab after Autologous Stem Cell Transplantation in Patients with T-Cell non-Hodgkin Lymphoma. Blood (2023)
Ariela L Marshall, Leah E Masselink, Peter A Kouides, Faith E Davies, Azam Farooqui, Srikanth Nagalla, Alex F Herrera, Nicole Mortier, Robert A Brodsky, Clese E Erikson
Advanced Practice Providers in Hematology: Actionable Findings from National Paired APP and Physician Surveys. Blood advances (2023)
Philippe Armand, Pier Luigi Luigi Zinzani, Jee Hun Lee, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A Shipp, Alex F Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H Moskowitz
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy in relapsed/refractory classical Hodgkin lymphoma. Blood (2023)
Swetha Kambhampati, Evgenii Shumilov, Monica Saumoy, Alex F Herrera, Hervé Tilly, Georg Lenz, Nikhil R Thiruvengadam
Cost-effectiveness of polatuzumab vedotin in combination with chemoimmunotherapy (pola-R-CHP) in previously untreated diffuse large B-cell lymphoma in Germany. British journal of haematology (2023)
Shin Yeu Ong, Stacy Pak, Matthew G Mei, Yan Wang, Leslie Popplewell, John H Baird, Alex F Herrera, Geoffrey Shouse, Liana Nikolaenko, Jasmine M Zain, James Godfrey, Myo Htut, Ahmed Aribi, Ricardo Spielberger, Joshua Mansour, Stephen J Forman, Joycelynne Palmer, L Elizabeth Elizabeth Budde
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma. American journal of hematology (2023)
Alex F Herrera, Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus K Poku, James Bading, Paul Yazaki, Savita Dandapani, Matthew Mei, Robert Chen, Thai Cao, Nicole Karras, Pamela McTague, Auayporn Nademanee, Leslie Popplewell, Firoozeh Sahebi, John E Shively, Jennifer Simpson, D Lynne Smith, Joo Song, Ricardo Spielberger, Ni-Chun Tsai, Sandra H Thomas, Stephen J Forman, David Colcher, Anna M Wu, Jeffrey Wong, Eileen Smith
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma. Blood advances 5 (23) (2022)
Jibin Zhang, Tingting Wang, Kunal Shetty, Serhan Alkan, Senlin Xu, Qiang Gong, Xuxiang Liu, Yuping Li, Zunsong Hu, Wendong Huang, Hans-Guido Wendel, Alex F Herrera, Raju K Pillai, Joo Y Song, Wing C John Chan
Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines. Blood advances 6 (17) (2022)
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara Moyo, Nishitha Reddy, Julia Whitley Sheets, David M Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C Churnetski, Andrew Hsu, Luke D Zurbriggen, Xiao-Wei Cherie Tan, Kathryn G Lindsey, Joseph Maakaron, Paolo F Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P Kenkre, Adam J Olszewski, Jonathon B Cohen, Neil Palmisiano, Elvira R Umyarova, Ryan A Wilcox, Farrukh T Awan, Juan Pablo Alderuccio, Stefan K Barta, Natalie Sophia Grover, Nilanjan Ghosh, Nancy L Bartlett, Alex F Herrera, Geoffrey Shouse
Postibrutinib relapse outcomes for patients with marginal zone lymphoma. Blood advances (2022)
Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Kristin M McHugh, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, Arnold S Freedman, Eric D Jacobsen, Caron A Jacobson, Austin I Kim, Ann Steward LaCasce, Samuel Y Ng, Oreofe O Odejide, Erin M Parry, Heather Jacene, Hyesun Park, Parastoo B Dahi, Yago L Nieto, Robin M Joyce, Yi-Bin Chen, Margaret A Shipp, Alex F Herrera, Philippe Armand
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Blood advances (2022)
Juan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, Anne W Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B Alpert, Adam J Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J Castillo, Lisa Argnani, Timothy J Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M Reis, Deukwoo Kwon, Jonathan Struan Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian L Link, Constantine N Logothetis, Alex F Herrera, Jonathan W Friedberg, Brad S Kahl, Stefano Luminari, Pier Luigi Luigi Zinzani, Izidore S Lossos
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood advances 6 (7) (2022)
Matthew G Mei, Hun Ju Lee, Joycelynne M Palmer, Robert Chen, Ni-Chun Tsai, Lu Chen, Kathryn McBride, D Lynne Smith, Ivana Melgar, Joo Y Song, Kimberley-Jane Bonjoc, Saro H Armenian, Mary Nwangwu, Peter P Lee, Jasmine Zain, Liana Nikolaenko, Leslie Popplewell, Auayporn Nademanee, Ammar Ahmed Chaudhry, Steven Rosen, Larry Kwak, Stephen J Forman, Alex F Herrera
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE. Blood 139 (25) (2022)
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, L Elizabeth Elizabeth Budde, Matthew G Mei, Tanya Siddiqi, Leslie L Popplewell, Yi-Ping Wen, Jasmine M Zain, Stephen J Forman, Larry W Kwak, Steven T Rosen, Alexey V Danilov, Alex F Herrera, Nikhil Thiruvengadam
Cost Effectiveness of Polatuzumab Vedotin Combined with Chemoimmunotherapy in Untreated Diffuse Large B-cell Lymphoma. Blood (2022)
Alex F Herrera, Samuel Tracy, Brandon Croft, Stephen Samuel Opat, Jill Ray, Alex F Lovejoy, Lisa Musick, Joseph N Paulson, Laurie Helen Sehn, Yanwen Jiang
Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA. Blood advances 6 (6) (2022)
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, L Elizabeth Elizabeth Budde, Matthew G Mei, Leslie L Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen J Forman, Larry W Kwak, Steven T Rosen, Alexey V Danilov, Alex F Herrera, Nikhil R Thiruvengadam
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma. Blood 140 (19) (2022)
Mehdi Hamadani, Maud Ngoya, Anna Sureda, Qaiser Bashir, Carlos Alejandro Litovich, Hervé Finel, Yue Chen, Ariane Boumendil, Jasmine Zain, Luca Castagna, Amanda F Cashen, Didier Blaise, Mazyar Shadman, Rocco Pastano, Farhad Khimani, Mutlu Arat, Sascha Dietrich, Norbert Schmitz, Bertram Glass, Mohamed A Kharfan-Dabaja, Paolo Corradini, Craig S Sauter, Silvia Montoto, Mi Kwon, Alex F Herrera, Peter Dreger
Outcome of Allogeneic Transplantation for Mature T-cell Lymphomas: Impact of Donor Source and Disease Characteristics. Blood advances (2021)
Alex F Herrera, Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir, Ruthee-Lu Bayer, Melanie Coleman, Zachariah DeFilipp, Nosha Farhadfar, Matthew Greenwood, Theresa Hahn, Mitchell Horwitz, Caron Jacobson, Samantha M Jaglowski, Sylvie Lachance, Amelia A Langston, Bassam Mattar, Richard T Maziarz, Joseph P McGuirk, Mohammad A H Mian, Sunita Nathan, Adrienne Phillips, Kevin Rakszawski, Henrik Sengeloev, Shalini Shenoy, Robert Stuart, Craig S Sauter, Mohamed A Kharfan-Dabaja, Mehdi Hamadani
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome. Blood advances 5 (18) (2021)
Alex F Herrera, Catherine Burton, John Radford, Fiona Miall, William Townsend, Armando Santoro, Pier Luigi Luigi Zinzani, David Lewis, Camilla Fowst, Satjit Brar, Bo Huang, Aron Thall, Graham P Collins
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial. Blood advances 5 (17) (2021)
Jennifer L Crombie, Loretta J Nastoupil, Kevin Tang, Geoffrey Shouse, Alex F Herrera, Victor A Chow, Mazyar Shadman, Omar Castaneda Puglianini, Anna Saucier, Caron A Jacobson, Philippe Armand, Gary Simmons
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma. Blood advances 5 (18) (2021)
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, Carlos Litovich, Claudio G Brunstein, Amanda F Cashen, Jonathon B Cohen, Narendranath Epperla, Brian T Hill, Annie Im, David J Inwards, John Lister, John M McCarty, Sai Ravi Kiran Pingali, Mazyar Shadman, Paul Shaughnessy, Melhem Solh, Patrick J Stiff, Julie M Vose, Mohamed A Kharfan-Dabaja, Alex F Herrera, Craig S Sauter, Sonali M Smith
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. British journal of haematology 195 (5) (2021)
Mazyar Shadman, Marcelo C Pasquini, Kwang Woo Ahn, Yue Chen, Cameron J Turtle, Peiman Hematti, Jonathon B Cohen, Farhad Khimani, Siddhartha Ganguly, Reid W Merryman, Jean A Yared, Frederick L Locke, Nausheen Ahmed, Pashna Munshi, Amer Beitinjaneh, Patrick Reagan, Alex F Herrera, Craig S Sauter, Mohamed A Kharfan-Dabaja, Mehdi Hamadani
Autologous Transplant versus Chimeric Antigen Receptor T-cell Therapy for Relapsed DLBCL in Partial Remission. Blood (2021)
Michael J Dickinson, Javier Briones, Alex F Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma. Blood advances 5 (22) (2021)
Narendranath Epperla, Alex F Herrera
How I incorporate novel agents into the treatment of classical Hodgkin lymphoma. Blood 138 (7) (2021)
Laurie H Sehn, Mark Hertzberg, Stephen Samuel Opat, Alex F Herrera, Sarit Assouline, Christopher R Flowers, Tae Min Kim, Andrew K McMillan, Muhit Özcan, Violaine Safar, Gilles Andre Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J Matasar
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort. Blood advances (2021)
Nicole A Carreau, Philippe Armand, Reid W Merryman, Ranjana H Advani, Michael A Spinner, Alex F Herrera, Radhakrishnan Ramchandren, Muhammad S Hamid, Sarit Assouline, Raoul Santiago, Nina Wagner-Johnston, Suman Paul, Jakub Svoboda, Steven M Bair, Stefan K Barta, Sunita Nathan, Reem Karmali, Pallawi Torka, Kevin David, Frederick Lansigan, Daniel O Persky, James Godfrey, Julio C Chavez, Yuhe Xia, Catherine S Diefenbach
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy. British journal of haematology 191 (1) (2020)
Marcus Geer, Emily K Roberts, Maryann Shango, Brian G Till, Stephen D Smith, Hashim Abbas, Brian T Hill, Jason Kaplan, Paul M Barr, Paolo Caimi, Deborah M Stephens, Emily Lin, Alex F Herrera, Evan Rosenbaum, Jennifer E Amengual, Philip S Boonstra, Sumana Devata, Ryan A Wilcox, Mark S Kaminski, Tycel Jovelle Phillips
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. British journal of haematology 186 (2) (2019)
Alex F Herrera, Andre Goy, Amitkumar Mehta, Radhakrishnan Ramchandren, John M Pagel, Jakub Svoboda, Shanhong Guan, John S Hill, Kevin Kwei, Emily A Liu, Tycel Phillips
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphoma. American journal of hematology 95 (1) (2019)